Pi3 Kinase P85 Antibody
The Phosphoinositide 3-kinase (PI3K) pathway is one of the most frequently activated signaling pathways in human cancer, regulating vital cellular functions such as growth, survival, and metabolism. The PI3K enzyme is a heterodimer consisting of a catalytic subunit and a regulatory subunit. The p85 antibody is a specific research tool used to detect the p85 regulatory subunit of this enzyme, which plays a crucial role in stabilizing the catalytic subunit and mediating its recruitment to the cell membrane.
In the laboratory, the Pi3 Kinase p85 antibody is used in techniques such as Western blotting, immunohistochemistry, and immunoprecipitation. By measuring the expression and phosphorylation state of p85, researchers can determine the activity level of the PI3K pathway in various cell types and disease states. This is particularly important in cancer research, as mutations in the PI3K pathway can lead to constitutive activation, driving tumor growth and resistance to therapy.
The use of this antibody has been instrumental in identifying how various growth factors and oncogenes trigger PI3K signaling. It also serves as a critical biomarker in clinical trials for PI3K inhibitors, helping researchers verify that a drug is successfully hitting its target. As we move deeper into the era of molecularly targeted therapy, tools like the p85 antibody remain essential for deconstructing the complex signaling networks that underpin human disease.
